FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31

Fulgent Genetics, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026

$20.10+0.29 (+1.46%)

Close on Oct 19, 2026

Market cap: $562.90M
P/E (TTM): –
Dividend yield: –

Fulgent Genetics, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31
Cash & Equivalents	50	55	97	80	165	87	12	6.74	6.49	7.90	0.49	–	–
Short-Term Investments	286	203	–	–	–	212	16	24	20	–	–	–	–
Cash & Short-Term Investments	336	258	97	80	165	299	28	31	26	7.90	0.49	–	–
Receivables	85	69	51	53	139	184	6.56	5.95	4.01	4.36	2.12	–	–
Prepaid Expenses & Other	5.10	6.63	7.74	6.81	4.24	3.68	1.29	0.56	0.62	0.38	0.07	–	–
Other Current Assets	23	23	33	49	23	40	2.26	2.56	2.44	0.91	0.31	–	–
Total Current Assets	550	354	508	628	612	524	37	40	33	26	2.93	–	–
Property, Plant & Equipment	113	106	83	81	62	40	5.97	6.45	7.27	6.23	2.47	–	–
Gross Property, Plant & Equipment	170	157	135	125	82	51	14	12	11	8.28	3.37	–	–
Accumulated Depreciation	-58	-52	-52	-43	-20	-11	-7.99	-5.89	-3.77	-2.05	-0.90	–	–
Long-Term Investments	369	570	424	327	485	133	42	6.39	15	–	–	–	–
Equity Method Investments	–	–	–	–	–	–	0.87	1.51	1.94	0	–	–	–
Operating Lease Right-of-Use Assets	4.96	5.40	11	15	7.14	0.83	2.63	3.00	–	–	–	–	–
Goodwill	25	22	22	143	51	–	–	–	–	–	–	–	–
Intangible Assets	133	135	143	151	36	–	–	–	–	–	–	–	–
Other Long-Term Assets	23	33	35	44	11	4.14	0.25	0.02	0.04	0.02	–	–	–
Total Assets	1,214	1,220	1,235	1,386	1,279	700	89	54	57	58	5.83	–	–
Accounts Payable	19	18	15	23	20	26	1.58	1.31	2.09	2.76	0.31	–	–
Accrued Expenses	34	24	31	25	18	8.45	1.33	1.26	0.91	0.44	0.20	–	–
Current Portion of Leases	1.46	1.44	3.96	6.13	1.84	0.27	0.42	0.38	–	–	–	–	–
Current Income Taxes Payable	–	–	–	–	0.79	53	0.02	–	–	0.12	–	–	–
Deferred Revenue (Current)	3.64	2.23	2.87	3.20	15	27	0.37	0.17	–	–	–	–	–
Other Current Liabilities	–	–	0.16	5.30	0.68	0.08	–	–	–	–	–	–	–
Total Current Liabilities	85	73	73	88	105	130	3.72	2.74	3.00	3.32	0.69	–	–
Long-Term Debt	1.96	2.49	2.96	3.37	–	–	–	–	–	–	–	–	–
Long-Term Leases	3.78	4.12	7.15	8.80	5.34	0.57	2.26	2.60	–	–	–	–	–
Operating Lease Liabilities	5.24	5.56	11	15	7.19	0.84	2.68	3.00	–	–	–	–	–
Deferred Tax Liabilities	6.94	6.37	7.96	–	–	–	–	–	–	0.24	–	–	–
Other Long-Term Liabilities	7.62	6.97	15	18	6.81	0.58	–	0.01	0.01	0.00	–	–	–
Total Liabilities	107	91	102	116	113	131	5.98	2.75	3.01	3.56	0.69	–	–
Total Debt	1.96	2.49	2.96	3.37	–	–	–	–	–	–	–	–	–
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	–	–	–
Additional Paid-In Capital	575	543	502	487	502	418	146	114	112	110	–	–	–
Retained Earnings	530	590	633	801	658	151	-63	-63	-58	-55	-53	–	–
Comprehensive Income & Other	7.51	-0.37	1.21	-21	-0.76	0.44	0.15	-0.04	-0.04	-0.10	–	–	–
Shareholders' Equity	1,112	1,133	1,136	1,267	1,159	569	83	51	54	54	5.15	1.68	1.97
Noncontrolling Interest	-5.27	-4.07	-2.82	3.19	7.13	–	–	–	–	–	–	–	–
Total Equity	1,107	1,129	1,133	1,270	1,166	569	83	51	54	54	5.15	1.68	1.97
Total Liabilities & Equity	1,214	1,220	1,235	1,386	1,279	700	89	54	57	58	5.83	–	–
Shares Outstanding(shares)	31	31	30	29	30	28	21	18	18	18	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 35.6%
Operating margin: -37.7%
Net margin: -26.0%
Return on equity, FY2025: -5.4%

Financial strength

Current ratio: 6.34
Debt to equity: 0.00
Debt to assets: 0.1%
Cash to current liabilities: 36.7%

Valuation

P/E ratio: –
Price to sales: 1.74
Price to book: 0.56
Dividend yield: –